Literature DB >> 7951640

Divalproex sodium in the treatment of aggressive behavior.

J Wilcox1.   

Abstract

Divalproex sodium was given to a series of agitated individuals with a variety of psychiatric illnesses. Objective measures of agitation were then used to assess the effect of the divalproex sodium on such behavior. Demographic, diagnostic, medical, and physiological data were compiled on the subjects and the variation in the amount of time spent in an agitated state was evaluated in an attempt to account for the variation. We found that divalproex sodium reduced agitation in a variety of psychiatric conditions. It seems to be especially effective in the treatment of the agitated patient with bipolar illness or borderline personality disorder.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7951640     DOI: 10.3109/10401239409148834

Source DB:  PubMed          Journal:  Ann Clin Psychiatry        ISSN: 1040-1237            Impact factor:   1.567


  5 in total

1.  Pregabalin- and topiramate-mediated regulation of cognitive and motor impulsivity in DBA/2 mice.

Authors:  Francisco Navarrete; José M Pérez-Ortiz; Jorge Manzanares
Journal:  Br J Pharmacol       Date:  2012-09       Impact factor: 8.739

2.  Symptomatic response to divalproex in subtypes of conduct disorder.

Authors:  Ranjit Padhy; Kirti Saxena; Lisa Remsing; Julia Huemer; Belinda Plattner; Hans Steiner
Journal:  Child Psychiatry Hum Dev       Date:  2011-10

3.  Divalproex sodium for the treatment of PTSD and conduct disordered youth: a pilot randomized controlled clinical trial.

Authors:  Hans Steiner; Kirti S Saxena; Victor Carrion; Leena A Khanzode; Melissa Silverman; Kiki Chang
Journal:  Child Psychiatry Hum Dev       Date:  2007-06-15

Review 4.  Efficacy and tolerability of pharmacotherapies for borderline personality disorder.

Authors:  Silvio Bellino; Erika Paradiso; Filippo Bogetto
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

5.  Borderline personality disorder: bipolarity, mood stabilizers and atypical antipsychotics in treatment.

Authors:  Hasan Belli; Cenk Ural; Mahir Akbudak
Journal:  J Clin Med Res       Date:  2012-09-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.